Fennec Pharmaceuticals (FENC) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,958.20+0.48%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Fennec Pharmaceuticals Inc (FENC) Stock Price, Quote, News & History

FENCNASDAQ

Trade with Public

Trade with Public

$10.71

0.080.75%

Last update: Oct 9, 7:36 PM

$10.60

-0.03-0.28%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$10.66

Close

$10.71

Volume / Avg.

93.46K / 191.17K

Day Range

$10.60 - $10.60

52 Wk Range

5.65 - 13.25

Market Cap

$372.76M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

1.69%

Days to Cover

3.85

Recent Fennec Pharmaceuticals Inc. News

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Fennec Pharmaceuticals (FENC) to release Q4 earnings on March 24. Analysts expect EPS of $0.04 and revenue of $14.73 million. Stock gained 1.8% on Monday.

Avi Kapoor

Pedmark Delivers In Japan Study — Less Hearing Loss, Same Cancer-Fighting Power

Pedmark cut cisplatin-related hearing loss in a Japan trial, with strong safety and no impact on tumor response, supporting plans for Japan registration.

Vandana Singh

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.

Erica Kollmann

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.04M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

24.58M

Free Cash Flow (TTM)

-2.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

22.54M

Analyst Trends and Forecast

1

Apr

1

May

2

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$329.78M

PE Ratio (TTM)

-

PE Ratio (FWD)

10.72

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.02

PB Ratio (TTM)

8.80

Earnings Yield % (TTM)

-1.13%

Earnings Yield % (FWD)

9.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.21

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$41.25M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-